Ensysce Biosciences, Inc. (ENSC) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 961K | 0 | 493.1K | 1.37M | 1.32M | 1.3M | 3.42M | 181.8K | 305.72K | 515.03K | 435.38K | 490.47K |
| Revenue Growth % | -27.2% | -100% | -85.58% | 654.38% | 331.76% | 153.12% | 685.26% | -62.93% | -61.28% | -64.07% | 55.85% | 136.41% |
| Cost of Goods Sold | 6.53K | 0 | 2.95M | 1.92M | 0 | 3.8M | 1.69M | 947.23K | 778.9K | 2.23M | 1.91M | 1.64M |
| COGS % of Revenue | 0.68% | - | 599.25% | 140.25% | - | 291.69% | 49.46% | 521.04% | 254.78% | 433.52% | 439.84% | 335.13% |
| Gross Profit | 954.47K | 0 | -2.46M | -551.99K | 1.32M | -2.5M | 1.73M | -765.43K | -473K | -1.72M | -1.48M | -1.15M |
| Gross Margin % | 99.32% | - | -499.25% | -40.25% | 100% | -191.69% | 50.55% | -421.04% | -154.72% | -333.52% | -339.84% | -235.13% |
| Gross Profit Growth % | -27.69% | 100% | -242.45% | 27.88% | 379.07% | -45.48% | 216.8% | 33.63% | 53% | 65.7% | 66.95% | 77.4% |
| Operating Expenses | 4.52M | 2.78M | 1.28M | 1.2M | 3.29M | 1.08M | 1.08M | 1.19M | 1.37M | 1.44M | 1.23M | 1.14M |
| OpEx % of Revenue | 470% | - | 259.44% | 87.39% | 249.04% | 82.65% | 31.68% | 654.58% | 448.12% | 279.2% | 281.99% | 232.57% |
| Selling, General & Admin | 1.18M | 1.05M | 1.28M | 1.2M | 1.4M | 1.08M | 1.08M | 1.19M | 1.37M | 1.44M | 1.23M | 1.14M |
| SG&A % of Revenue | 122.41% | - | 259.44% | 87.39% | 106.21% | 82.65% | 31.68% | 654.58% | 448.12% | 279.2% | 281.99% | 232.57% |
| Research & Development | 3.35M | 3.61M | 2.95M | 1.92M | 1.89M | 3.8M | 1.69M | 947.23K | 778.9K | 2.23M | 1.91M | 1.64M |
| R&D % of Revenue | 348.27% | - | 599.25% | 140.25% | 142.88% | 291.69% | 49.46% | 521.04% | 254.78% | 433.52% | 439.84% | 335.13% |
| Other Operating Expenses | 0 | -1000K | -1000K | -1000K | -716 | -1000K | -1000K | -947.23K | -778.9K | -1000K | -1000K | -1000K |
| Operating Income | -3.56M | -2.78M | -3.74M | -1.75M | -1.97M | -3.58M | 644.75K | -1.96M | -1.84M | -3.16M | -2.71M | -2.29M |
| Operating Margin % | -370.68% | - | -758.68% | -127.64% | -149.09% | -274.34% | 18.86% | -1075.62% | -602.84% | -612.72% | -621.83% | -467.7% |
| Operating Income Growth % | -81.01% | 22.22% | -680.24% | 10.48% | -6.78% | -13.33% | 123.82% | 14.76% | 28.04% | 49.11% | 56.07% | 67.48% |
| EBITDA | -3.56M | -2.76M | 0 | 0 | -1.94M | 0 | 665.83K | 0 | -1.87M | 0 | 0 | 0 |
| EBITDA Margin % | -370.68% | - | - | - | -147.12% | - | 19.48% | - | -611.01% | - | - | - |
| EBITDA Growth % | -83.43% | - | -100% | - | -3.96% | - | - | - | - | 100% | 100% | 100% |
| D&A (Non-Cash Add-back) | 0 | 0 | 3.74M | 1.75M | 0 | 3.58M | 0 | 1.96M | 0 | 3.16M | 2.71M | 2.29M |
| EBIT | -3.56M | -2.76M | -3.72M | -1.75M | -1.94M | -3.58M | 665.83K | -1.96M | -1.87M | -3.16M | -2.71M | -2.29M |
| Net Interest Income | -3.92K | -5.38K | -6.37K | -3.16K | -3.86K | -10.75K | -4.06K | -27.56K | -1.25M | -345K | -7.65K | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.92K | 5.38K | 6.37K | 3.16K | 3.86K | 10.75K | 4.06K | 27.56K | 1.25M | 344.8K | 7.65K | 0 |
| Other Income/Expense | 5.82K | 13.86K | 11.97K | 17K | 21.94K | 12.05K | 17.02K | -12.35K | -1.27M | -348.68K | 16.51K | 54.65K |
| Pretax Income | -3.56M | -2.77M | -3.73M | -1.73M | -1.95M | -3.56M | 661.77K | -1.97M | -3.12M | -3.5M | -2.69M | -2.24M |
| Pretax Margin % | -370.07% | - | -756.26% | -126.4% | -147.42% | -273.42% | 19.36% | -1082.41% | -1019.55% | -680.42% | -618.04% | -456.56% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.56M | -2.77M | -3.73M | -1.73M | -1.95M | -3.56M | 661.77K | -1.97M | -3.12M | -3.5M | -2.69M | -2.23M |
| Net Margin % | -370.07% | - | -756.26% | -126.39% | -147.42% | -273.42% | 19.36% | -1082.41% | -1019.23% | -680.23% | -617.75% | -455.12% |
| Net Income Growth % | -82.76% | 22.35% | -663.51% | 11.91% | 37.55% | -1.74% | 124.61% | 11.85% | -42.42% | 36.19% | 72.65% | 72.09% |
| Net Income (Continuing) | -3.56M | -2.77M | -3.73M | -1.73M | -1.95M | -3.56M | 661.77K | -1.97M | -3.12M | -3.5M | -2.69M | -2.24M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -328.97K | -328.97K | -328.65K | -328.65K | -328.48K | -328.48K | -328.48K | -328.48K | -328.48K | -328.41K | -327.44K | -326.21K |
| EPS (Diluted) | -0.52 | -0.51 | -1.29 | -0.79 | -1.39 | -2.90 | 0.35 | -0.98 | -1.46 | -1.55 | -0.87 | -0.98 |
| EPS Growth % | 62.59% | 82.41% | -468.57% | 19.39% | 4.79% | -87.1% | 140.23% | 0% | 29.81% | 91.5% | 98.97% | 98.27% |
| EPS (Basic) | -0.52 | -0.75 | -1.29 | -0.79 | -1.39 | -2.90 | 1.00 | -0.98 | -1.46 | -1.55 | -0.87 | -0.98 |
| Diluted Shares Outstanding | 6.84M | 25.57M | 2.89M | 2.2M | 1.4M | 1.23M | 1.88M | 2M | 2.13M | 2.26M | 3.09M | 2.27M |
| Basic Shares Outstanding | 6.84M | 2.56M | 2.89M | 2.2M | 1.4M | 1.23M | 2M | 2M | 2.13M | 2.26M | 3.09M | 2.27M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |